Changhua Zhuo

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Chemotherapy Induced

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Shen Zhao, LiYu Su, Feng Huang, Changhua Zhuo, Zaisheng Ye, Hui Li, Yi Yin, Pengqiang Gao, Yong Zhu, Rong-Bo Lin
Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancer. Cancer science (2024)
Shen Zhao, LiYu Su, Feng Huang, Changhua Zhuo, Zaisheng Ye, Hui Li, Yi Yin, Pengqiang Gao, Yong Zhu, Rong-Bo Lin
Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancer. Cancer science 115 (5) (2024)
Shen Zhao, LiYu Su, Feng Huang, Changhua Zhuo, Zaisheng Ye, Hui Li, Yi Yin, Pengqiang Gao, Yong Zhu, Rong-Bo Lin
Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancer. Cancer science 115 (5) (2024)
Shen Zhao, LiYu Su, Feng Huang, Changhua Zhuo, Zaisheng Ye, Hui Li, Yi Yin, Pengqiang Gao, Yong Zhu, Rong-Bo Lin
Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancer. Cancer science 115 (5) (2024)
Shen Zhao, LiYu Su, Feng Huang, Changhua Zhuo, Zaisheng Ye, Hui Li, Yi Yin, Pengqiang Gao, Yong Zhu, Rong-Bo Lin
Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancer. Cancer science 115 (5) (2024)